TGTiffany Grezmak

Tiffany Grezmak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tiffany Grezmak has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Rachel Galioto

    Mellen Center for Multiple Sclerosis Neurological Institute Cleveland Clinic Cleveland Ohio USA

    2 shared publications
  • Amy Kunchok

    Department of Neurology, Mellen Center for Multiple Sclerosis Cleveland Clinic Cleveland Ohio USA

    1 shared publication
  • Carol Swetlik

    From the Cleveland Clinic Mellen Center for MS (R.G., J.R.A., A.K.); Department of Neurology (T.G., C.S.), Cleveland Clinic, OH; Neurology (M.J.T.), Erasmus University Medical Center, Rotterdam, Netherlands; Department of Neurology (C.F.), Charité - Universitätsmedizin Berlin, Germany

    1 shared publication
  • Carsten Finke

    Department of Neurology and Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany

    1 shared publication
  • Daniel Ontaneda

    Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH USA

    1 shared publication
  • John W. Lace

    Neurological Institute, Section of Neuropsychology, Cleveland Clinic, Cleveland, OH USA

    1 shared publication

Latest Publications

  • Open Access

    Neuropsychological Testing in Autoimmune Encephalitis

    by Rachel Galioto, Tiffany Grezmak, Carol Swetlik, Justin R. Abbatemarco, Maarten J. Titulaer, Carsten Finke, Amy Kunchok

    Background and Objectives Identifying optimal methods for evaluation and monitoring of cognitive outcomes in AE is important for clinical care and research. This scoping review aimed to evaluate neuropsychological tests (NPT) that are most frequently impaired in AE cohorts to provide recommendations for a standardized NPT battery for AE outcome. Methods PubMed search for studies examining NPT in patients with AE was conducted on June 9, 2023. Studies were screened for inclusion/exclusion criteria as follows: at least 1 NPT, individual NPT test scores with comparison with healthy controls or normative data and neural-IgG status, total sample size ≥5, and English manuscript available. Results The search yielded 5,393 studies, of which 3,359 were screened, 107 were full text reviewed, and 32 met inclusion/exclusion criteria, anti-NMDA-R (k = 18), anti-LGI1 (k = 10), anti-GABAB-R (k = 2), anti-GAD-65 (k = 4), and anti-CASPR2 (k = 3). The cognitive domains most frequently impaired were visual and verbal episodic memory, attention/working memory, processing speed, and aspects of executive functions. Discussion Given the dearth of literature examining NPT in AE in combination with small sample sizes and methodological differences, more research in this area is needed. However, we provide recommendations for a test battery to be used in future studies, with the aim of standardizing research in this area. Based on the available literature, we recommend the use of comprehensive NPT batteries, spanning all cognitive domains. The highest yield measures may include the tests of (1) visual and verbal learning/memory, (2) basic and sustained attention, (3) processing speed, and (4) executive functions.


  • Open Access

    A-200 “It’s on the Tip of My Tongue!” – Base Rates and Neuroanatomical Correlates of Confrontation Naming Deficits in Patients with Multiple Sclerosis

    by Tiffany Grezmak, John Lace, Rachel Galioto

    Objective: Word-finding difficulty is a commonly reported complaint in patients with multiple sclerosis (pwMS), though it is often under evaluated in clinical care. This study sought to identify base rates of confrontation naming impairments relative to other language tasks and examine its neuroanatomical correlates in pwMS. Method: Of 372 pwMS referred for neuropsychological assessment, 185 (MAge=48.8±11.23; MEd=14.5±2.4; 83% White; 73% women) met inclusion criteria for the final sample (i.e., estimated premorbid IQ ≥70, English-speaking, valid data on performance validity indices). Norm-based T scores for the following tests were of interest: Boston Naming Test (BNT); Controlled Oral Word Association Test (COWAT); and Animal Fluency (AF). A subset of 50 patients underwent recent quantitative MRI variables for whole brain fraction (WBF) and white matter lesion burden (T2LV). Results: PwMS showed greater impairment (≤1.5 SD) on the BNT (27.6%) as compared to AF (18.4%; p=.002), but not COWAT (24.3%; p=.304) based on binomial tests. Controlling for age and sex, significant partial correlations (ps<.05) were identified between BNT and both WBF (r=.32) and T2LV (r=-.30) and between AF and T2LV (r = -.30). COWAT did not correlate significantly with WBF (r=.08) or T2LV (r=-.09). Conclusions: Confrontation naming is relatively frequently impaired in pwMS, and correlates with both cerebral volume and lesion burden. Semantic fluency correlated only with lesion burden, and phonemic fluency did not correlate with neuroimaging. Future research should continue to investigate the clinical presentation and neuroanatomical underpinnings of language dysfunction, particularly naming/word-finding difficulties, in pwMS.